Metohexal (Metoprolol Succinate)

Metoprolol succinate, the active ingredient in Metohexal, is a beta blocker presented as a oral tablet for oral use. It treats hypertension, angina pectoris, heart failure and post‑myocardial infarction in adult patients. GNH USA supplies Metohexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Metohexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Metohexal is a beta‑adrenergic blocker that acts on the cardiovascular system to control blood pressure and heart workload.

- Hypertension: lowers systolic and diastolic blood pressure. - Angina pectoris: reduces frequency and severity of chest pain. - Heart failure: improves cardiac output and reduces hospitalization risk. - Post‑myocardial infarction: decreases risk of recurrent cardiac events.

Metoprolol      …  …  … … … … …